COMMUNIQUÉS West-GlobeNewswire

Evaxion Announces Completion of ADS Ratio Change
22/01/2024
COPENHAGEN, Denmark, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today [...]
ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
22/01/2024
SOLANA BEACH, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine [...]
ClearPoint Neuro annonce être arrivé pour la première fois au terme du processus de certification de conformité au Règlement européen MDR et obtenu l’autorisation d’expédier son produit en Europe
22/01/2024
SOLANA BEACH, Californie, 22 janv. 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq : CLPT (la « Société »), une entreprise internationale spécialisée dans les dispositifs médicaux, les thérapies cellulaires et [...]
Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call
22/01/2024
BANNOCKBURN, Ill., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced [...]
Oxurion Announces New Strategic Orientation to De-risk and Diversify
22/01/2024
Leuven, BELGIUM, 22 January 2024 9:00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announced today its new corporate strategy to further diversify its activities by [...]
ONWARD® to Participate in Basel Healthtech Conference 2024
22/01/2024
CEO Dave Marver will discuss the Company’s leadership in health technology, including spinal cord stimulation with brain-computer interfaces EINDHOVEN, the Netherlands, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N [...]
Remsleep Holdings Inc.'s DeltaWave Mask has received questions from FDA regarding 510k submission (K233415)
22/01/2024
TAMPA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to Obstructive Sleep Apnea (OSA) has [...]
Rahal Automotive Group Donates $35,000 to SoldierStrong to Help Military Veterans Take Their Next Steps Forward
22/01/2024
HARRISBURG, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- The Bobby Rahal Automotive Group today announced a $35,000 donation to SoldierStrong, a national nonprofit organization with a mission to deliver revolutionary medical [...]
SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference
22/01/2024
SMRSC 2024 brings global medical experts and technological innovators together to explore the future of robotic surgery 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the [...]
Nusano Names Rohan Jain as Commercial General Manager
22/01/2024
VALENCIA, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of medical radioisotopes, today announced Rohan Jain as its Commercial General Manager. Jain and his team will [...]
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
22/01/2024
- Placebo-Controlled Clinical Proof of Concept Data Expected in Mid-2024 - - Targeting Initiation of IMC-2 Phase 2 program in 2H 2024 - ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI [...]
AIM ImmunoTech Announces that the First Subject is Enrolled in the Phase 1b/2 Study Evaluating Ampligen® in Combination with AstraZeneca’s Imfinzi® for the Treatment of Late-Stage Pancreatic Cancer
22/01/2024
First enrollment takes place at Erasmus Medical Center in Rotterdam, Netherlands OCALA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the [...]
Pressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales
22/01/2024
Merged Companies Will Introduce Revolutionary New Product Capabilities Across Multiple Major Market Sectors, Expecting 2024 Revenues of Over $10 Million, Then Accelerating in Future Years SOUTH EASTON, Mass., Jan. 22, [...]
DGP Plc Takes Drug Testing In-house with Fingerprint Sweat-based Testing
22/01/2024
Construction logistics, security, and support specialist selects Intelligent Fingerprinting Drug Screening System to simplify and speed up workplace drug testing for its 450 employees and contractors “By using [...]
Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024
22/01/2024
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Biodexa CEO Issues Shareholder Letter Highlighting Progress in 2023 and Expected Milestones in 2024 CARDIFF, United Kingdom, Jan. 22, 2024 (GLOBE NEWSWIRE) – [...]
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
22/01/2024
Funding from new and existing investors including Viking Global Investors, Commodore Capital, Frazier Life Sciences, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), and Nextech Pro forma cash and [...]
RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
22/01/2024
Glen Rock, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Pink Market:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary [...]
3Daughters Successfully Closes Over $2 million in First Tranche of Seed Financing Round
22/01/2024
Funding will accelerate development of a Novel IUD for contraception for IND filing in 2024 MANSFIELD, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- 3Daughters , a clinical development company fueling evolutionary healthcare [...]
ReiThera Srl, The Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation
22/01/2024
Novel HIV vaccine candidate based on Gorilla adenoviral vector (GRAd-HIV) funded by the Bill & Melinda Gates Foundation to alleviate the disease burden and improve the lives of the millions who lack access to [...]

Pages